The treatment for TB is highly subsidized, with that for common TB virtually free of charge, said Li Liang, a veteran TB specialist in Beijing.
But efforts need to be further enhanced, particularly with the multidrug-resistant TB, or MDR-TB.
The WHO's 2015 Global TB Report said only three in 10 TB patients in China receive proper laboratory diagnosis, and five in 100 of all estimated MDR-TB patients are reported to receive proper treatment.